Last updated: September 17, 2026
A 409A valuation determines the fair market value of your company’s common stock so you can set an option exercise price that is not below grant-date FMV. Address that pricing—and the other stock-right exemption conditions—before you grant options. An outside appraisal is one common route to a regulatory presumption of reasonableness; it is not required in every case, and it does not by itself resolve every §409A issue.
Review grant terms, pricing support, and authorization together. A valuation report cannot cure an unrelated defect in the award.
What Is a 409A Valuation, and Why Does It Matter?
Section 409A governs nonqualified deferred compensation. Properly structured options and SARs can be exempt under its stock-right rules; RSUs may be exempt or subject to payment requirements; restricted stock generally falls under §83. Valuation of the underlying common stock helps establish an appropriate option strike, but does not decide every award’s tax treatment.
For a typical private-company NSO, a below-FMV strike does not automatically create grant-date income equal to the discount. It can cause the option to fall outside the stock-right exemption. A covered arrangement that fails §409A can trigger income inclusion for vested affected deferrals and additional taxes. Distinguish grant-date pricing, coverage, vesting and taxable inclusion. Incentive stock options are not simply “outside” §409A: an option that satisfies the applicable statutory-option and regulatory stock-right requirements generally falls within the stock-right exclusion, but an option purporting to be an ISO can create complications if its terms fail the applicable requirements. An above-FMV strike can satisfy the nondiscount pricing condition; the strike need not equal the valuation figure so long as it is not less than grant-date FMV.
An independent appraisal meeting the regulation’s conditions creates a rebuttable presumption that the valuation is reasonable. The other safe harbors described below can also provide that presumption. Pricing at FMV is only one condition of the stock-right exemption; qualifying stock and the absence of an additional deferral feature also matter.
A valuation outside a safe harbor may still satisfy the reasonable-valuation standard, but lacks that presumption. Missing an outside appraisal is not by itself proof of a violation or of discounted option pricing.
A note before you book: please share only the names of the parties and a brief, non-confidential description of your issue. Confidential details should wait until we’ve completed a conflicts check and signed a written engagement agreement.
Founders frequently ask a closely related question — are 409A valuations public — which we cover separately.
How Much Does a 409A Valuation Cost?
Fees vary with the valuation date, company stage, share classes, financing history, quality of records, service scope and deadline. Request current quotes that specify the report, update policy and support during an audit or financing. Compare a bundled platform service with a standalone engagement on qualifications, scope, independence and support. A bundled service is not inherently less independent, and price alone does not establish quality.
Budget for the valuation approach appropriate to your company and for updates before new grants when needed. The value is supportable pricing and documentation; an appraisal is not insurance against every award-design or operational failure.
How Section 409A Came to Exist: A Brief History
Section 409A was added in 2004 and generally applies to amounts deferred after 2004, with transition and grandfather rules. Before §409A, option taxation still had requirements: ISO pricing rules and §83 did not disappear merely because startup valuation practices were less formal.
A nominal strike was not universally permissible before §409A. In particular, ISO qualification already required the statutory relationship between strike price and grant-date FMV. Distinguish historical practice from the legal requirements for each option type.
Section 409A regulates the timing of nonqualified deferred compensation. Its application to a particular stock right depends on the exemption and compliance rules, not simply on whether an appraisal exists.
A grant-date error can affect option pricing and other tax requirements; investigate the actual authorization date and contemporaneous value before reaching a conclusion.
The final regulations supplied three valuation safe harbors, alongside the general reasonable-valuation standard. The independent-appraisal route became widely used, but the rules did not make purchasing an outside report the sole way to establish reasonable FMV. Without a safe harbor, support the valuation under the general standard. With a safe harbor, the IRS can rebut the presumption by showing that the method or its application was grossly unreasonable. Neither result establishes all the other requirements of an exempt stock right.
A common-stock valuation serves a defined purpose as of a defined date. It may also inform diligence or financial reporting, but its conclusion should not be treated as a universal measure of the company or of every security it has issued.
When Do You Need Supportable Grant-Date FMV?
Some founders treat a third-party appraisal as a one-time early ritual. Others are unsure when grant-date FMV support must be refreshed. The triggers are about supportable pricing for the grants you are making—not buying a report for its own sake.
Before granting stock rights intended to satisfy the exemption, establish supportable grant-date FMV and check the other exemption conditions. An outside appraisal is one route. Restricted stock generally falls under Section 83, where valuation also matters. If earlier grants lack support, reconstruct the facts before assuming a violation or selecting a correction.
Review developments before subsequent grants. The question is whether new information materially affects value, rather than whether an event appears on a generic checklist.
A financing can provide material new information that must be reflected before subsequent grants. A preferred-stock financing price is not automatically common-stock FMV, and a difference between the two does not itself trigger income tax. Reassess the common-stock value using the new information and the securities’ actual rights.
A change in revenue, cash burn, or another operating measure can require reassessment if it materially affects value. There is no universal revenue threshold that automatically triggers a new appraisal.
A business-model pivot, market change, or competitive development can make earlier assumptions unreliable. Record how the development affects the valuation rather than assuming every change has the same effect.
Acquisition discussions may supply material valuation information and may affect eligibility for the illiquid-startup safe harbor. Review the facts before further grants; an uncompleted transaction can still provide relevant evidence.
An arm’s-length secondary sale or tender offer can likewise be highly relevant evidence of common-stock value, depending on the securities sold, transaction size, participants, restrictions, and timing. It does not automatically reset every prior valuation, but new grants should not ignore representative secondary pricing.
For new grants, the regulation rejects a value more than 12 months old and a calculation that fails to reflect intervening material information. A company granting regularly therefore needs at least annual review, with earlier updates when required.
How 409A Valuations Actually Work: The Three Approaches
A private-company common-stock valuation is not a guess, but the §409A regulations do not mandate income, market, or asset approaches by name. In practice, appraisers often use one or more of those three approaches within an overall reasonable valuation method.
The income approach values your company based on the present value of its expected future cash flows. A valuation firm projects your revenue, expenses, and cash generation into the future, then discounts those cash flows back to today's dollars using a discount rate that reflects the risk of your business. This approach works well for companies with relatively predictable cash flows—a SaaS business with good visibility into recurring revenue, for example. The challenge is that early-stage startups often lack the track record to make reliable projections, which is where the other approaches come in.
The market approach looks at comparable companies—both public and private transactions—to determine what similar businesses are worth. If you're a Series A enterprise software company, the valuation firm might look at recent acquisitions of similar companies, comparable public company valuations, and venture capital investment terms. They apply multiples from these comparable transactions to your company's financials. This approach is useful because it's grounded in real market data, but it's only as good as the comparable companies you can actually identify.
The asset approach values the company based on the net value of its tangible and intangible assets. For most startups, this is the least relevant approach since startups typically don't have significant hard assets. You'd use this more for a capital-intensive business or one with valuable owned assets. But some valuations will use a cost approach or salvage value analysis as a check on the other methods.
Most 409A valuations weight these approaches differently depending on the company's stage and circumstances. An early-stage Series Seed company might rely heavily on the market approach (what did comparable recent fundings look like?). A more mature company with revenue might weight the income approach more heavily.
The Equity Allocation Methods: OPM, PWERM, CVM, and Hybrid
It helps to separate two steps that founders routinely run together. First, the appraiser determines your company's total equity value using the income, market, and asset approaches above. Second — and this is the part unique to companies with preferred stock — the appraiser allocates that value across share classes to isolate what the common stock is worth, since that is what your employees' options are priced against. The allocation step is where you'll hear four names.
The OPM Backsolve methodology comes from the options pricing method, and it is widely used for pre-revenue and early-revenue venture-backed startups. Here's how it works: the valuation firm takes the price paid by investors in your latest funding round and works backward to determine the implied equity value per share. If investors paid $10 per share for preferred stock in a Series A, and preferred stock has certain liquidation preferences and other rights that common stock doesn't have, the OPM backsolve calculates what common stock (which is what your employees receive) is worth. The methodology accounts for the fact that preferred stock has priority in liquidation, dividends, and other economic terms. It's elegant because it's grounded in actual market prices you just received. The downside is that it assumes the investor price is correct, and it requires making assumptions about future volatility and the probability of various exit scenarios.
PWERM—the probability-weighted expected return method—takes a different approach. Rather than starting with an investor price, PWERM projects several possible scenarios for your company's future and assigns a probability to each. One scenario might be acquisition at $100 million in three years. Another might be continued independent operation at a higher value. A third might be failure. You weight each scenario by its probability and the expected return for shareholders in each case, then discount back to today. This methodology is powerful because it forces founders and valuators to think realistically about different outcomes. It's particularly useful for later-stage companies with meaningful revenue where the range of possibilities is more constrained.
The Current Value Method (CVM) is the simplest allocation method. It assumes the company is sold or liquidated today at its current equity value, then distributes that value across the share classes strictly by their liquidation preferences and conversion rights — preferred first, with whatever is left going to common. Because it ignores future upside entirely, CVM is generally only appropriate for the very earliest companies or when a liquidity event is imminent; for most venture-backed startups it drives the common stock value toward zero whenever liquidation preferences exceed current equity value — ignoring the very real option value of common's future upside — which is why many appraisers prefer OPM in that setting.
The Hybrid Method blends PWERM and OPM and is commonly used for late-stage, pre-IPO companies. The appraiser assigns explicit probabilities to near-term exits (an IPO or acquisition) and values the common stock in those scenarios using a PWERM waterfall, then routes the remaining probability — every outcome other than the near-term exit — through an OPM scenario. It lets the valuation reflect a likely exit without pretending the other outcomes don't exist.
One label worth getting right: the comparable companies and comparable transactions analysis you'll see in a report is part of the market approach to determining total equity value — applying public-company trading multiples or M&A multiples to your financials. That is a different step from the allocation methods above, and it is not what "CVM" refers to.
Most sophisticated 409A valuations use multiple methodologies as a check. If the OPM backsolve suggests one value and comparable companies suggest something substantially different, the valuation firm has to reconcile that discrepancy and explain their conclusions. That triangulation is actually a sign of a rigorous valuation, not confusion.
Safe Harbor Provisions: The Rebuttable Presumption
The valuation safe harbors create a rebuttable presumption of reasonableness. They are not immunity from IRS examination or from unrelated §409A failures.
An appraisal satisfying the independent-appraisal safe harbor supports the valuation used to price the grant. Later business failure or lower share value does not by itself establish that grant-date value was wrong. The presumption still can be rebutted on the regulatory standard.
First identify which safe harbor applies. Independence is a condition of the independent-appraisal route; it is not a universal condition for the illiquid-startup route. Each route has requirements that must be satisfied at the relevant time.
The general standard requires reasonable application of a reasonable valuation method, considering the facts and available information. Each safe harbor supplies a rebuttable presumption under its own conditions; selecting a method by name alone is insufficient.
The Three Safe Harbor Methods
The regulation — Treas. Reg. §1.409A-1(b)(5)(iv)(B) — gives you three ways to earn the presumption of reasonableness, not one. Most founders only ever hear about the first.
- Independent appraisal. An eligible independent appraisal can support the regulatory presumption of reasonableness when its conditions are met. It does not make the appraiser “IRS-approved,” and it does not conclusively fix fair market value. The value must be as of a date no more than 12 months before the relevant transaction and must reflect intervening material information when used for a grant.
- Illiquid start-up valuation. The illiquid-startup method requires, among other conditions, no material trade or business conducted for 10 years or more by the company or a predecessor, no publicly traded equity class, and no reasonably anticipated qualifying change in control within 90 days or public offering within 180 days. The purchase-right restrictions have express exceptions for qualifying rights of first refusal and lapse restrictions. Use a good-faith written valuation by a person the company reasonably determines is qualified. Relevant knowledge, experience, education and training matter; an insider is not automatically disqualified.
- Binding formula. A qualifying formula must satisfy the regulation’s consistency and transfer-pricing conditions, including its specified exceptions. Consult Treas. Reg. §1.409A-1(b)(5)(iv)(B)(2)(ii); merely using the same formula for option grants is insufficient.
Select the valuation route based on the company and grant, not a universal financing-stage sequence. Receipt of seed funding does not itself establish illiquid-startup safe-harbor eligibility. Restricted stock requires its own Section 83 analysis.
One more layer: a recent financing price is highly relevant evidence in a 409A valuation, and valuation firms routinely use it as a key input (particularly through the OPM backsolve methodology). However, common-stock fair market value often differs from the preferred-stock financing price because of liquidation preferences, lack of marketability, and other economic differences; there is no simplistic fixed regulatory discount. There is no general regulatory rule that mechanically equates a financing round price with §409A fair market value, even if the valuation is done shortly after the round. (The 90-day reference you may have seen in other guides relates to a specific limitation on the startup-company safe harbor when a change-in-control event is reasonably anticipated within 90 days—a different concept entirely.)
How SAFE Rounds and Convertible Notes Change the Equation
Here's where many founders get confused: what's your 409A valuation when you've raised money through SAFEs or convertible notes that haven't converted yet?
A SAFE generally supplies contractual conversion rights rather than currently issued common shares. A convertible note has debt and conversion terms that must be examined. Neither instrument’s valuation cap automatically supplies the grant-date FMV of the common shares underlying an option; tax and accounting classification require their own analysis.
A SAFE or note cap is not automatically common-stock FMV. Treat it as an input to the instrument’s conversion economics—along with triggering events, capitalization definitions, and other terms—not as a representation of current common-stock value or a promise of a future financing price. Distinguish the conversion cap, total enterprise or equity value, and common-stock value per share; their numerators, denominators, and rights differ. An independent appraisal may be appropriate, but is not required solely because the company raised a SAFE round. There is no mandatory percentage discount from a conversion cap.
Price the option per share using supportable grant-date common-stock FMV and the applicable award rules. Using a higher assumed value can make exercise more expensive; an above-FMV strike alone does not establish every condition for §409A exemption. Do not compare a company-level dollar valuation directly to a per-share strike.
After a SAFE or note converts, you may need to re-evaluate your 409A. If the conversion establishes a real price per share (because there's a Series A and the SAFE converts at a discount), that new price becomes important for your next 409A valuation.
The Relationship Between Fundraising Valuations and Fair Market Value
⚡ KEY INSIGHT: A Startup Has Many Valuations
When founders hear "valuation," they assume there's one number. There isn't. A startup carries several valuations simultaneously, each serving a different purpose:
- The financing valuation reflects negotiated investment terms and the securities being purchased. It is not automatically the common-stock FMV used for option pricing.
- The 409A common-stock valuation supports option pricing as of a specified date. An independent appraisal is one safe-harbor route; the resulting share value is not the fair value of the option award itself.
A preferred financing price and common-stock FMV can differ because the securities have different economic rights. Compare per-share values on consistent capitalization and valuation dates, and support the allocation. A difference alone does not establish that either number is correct.
A financing’s $40 million post-money headline value cannot directly establish a per-share common-stock option strike. Reconcile the financing terms, capitalization, valuation date and share-class rights before using the financing evidence.
A financing valuation reflects negotiated investment terms; the common-stock FMV determination must consider those terms and other relevant information as of the valuation date. An outside appraisal is one permitted method of establishing the regulatory presumption.
Here's the tension: preferred stock has rights that common stock doesn't. Liquidation preferences, dividend rights, anti-dilution protections, conversion privileges. These are valuable. So investors pay a premium for preferred stock. When you issue common stock options to employees, they're not getting those rights—they're getting plain common stock.
Compare like units. A financing’s total post-money value and a common-stock price per share are not directly comparable. Preferred rights may affect allocation among classes, but there is no prescribed discount or inverse relationship between the two values.
A supportable common-stock valuation should account for a recent fundraising round and other market evidence, adjust for the fact that option holders receive common stock rather than preferred, and reflect relevant assumptions about outcomes and dilution.
A lower common-stock price can be supportable when preferred shares have more valuable economic rights. Explain the allocation and assumptions rather than relying on a stock percentage of the financing valuation.
A difference between a financing headline value and a valuation report is a reason to reconcile dates, capitalization, security rights and units. The direction or size of that difference alone does not prove that the report is wrong.
409A Audit Defense: What the IRS Actually Looks At
An IRS examination can challenge the valuation method, its application and grant-date FMV. The safe harbor affects the burden of rebutting reasonableness; it does not prevent the IRS from examining historical pricing. Retain the information supporting the valuation used for each grant.
- Correct safe-harbor conditions. Independence matters for the independent-appraisal route; a qualified insider can satisfy the illiquid-startup route if all its conditions are met.
- Documentation of the methodology. Explain the valuation and allocation methods appropriate to the company, with supporting facts. The regulation does not mandate OPM, PWERM or CVM by name.
- Treatment of recent material events. Assess whether later information materially affects value and whether the calculation reflects it.
- Consistency with internal records. Reconcile differences between valuation assumptions and contemporaneous board materials, projections, and financing records.
- Timing relative to grants. Check the age and information supporting the value used on each actual grant date.
Retain the information supporting each grant’s pricing. A later reviewer should be able to identify the valuation date, assumptions, and material information considered.
M&A diligence, financial-statement work, and IPO preparation can also surface historical grant-pricing issues. Maintain valuation and approval records as grants are made; the response to a defect depends on its facts rather than an automatic escrow or repricing outcome.
Board Adoption: The Minutes Language That Matters
Document grant authorization and the valuation relied upon. The regulation does not impose a universal separate board vote adopting each appraisal as a valuation safe-harbor condition. Follow applicable board or delegated authority, governing documents, and award terms. See DGCL §157.
Useful details often recorded in practice (not a universal federal §409A checklist) include:
- The appraiser by name and firm
- The effective date of the valuation
- The per-share fair market value adopted
- The methodology used (e.g., OPM Backsolve, PWERM)
- A statement that the board reviewed the report and adopted the FMV for purposes of granting equity awards
These records help explain the decision. Minutes do not independently prove valuation reasonableness or guarantee an audit or diligence outcome.
ASC 718 vs. 409A: Why GAAP Fair Value Isn't Tax Fair Value
Founders preparing for an audit or a financing often discover that their auditor uses a different fair value number than their 409A. That is not a mistake. Section 409A and ASC 718 (Stock Compensation under GAAP) are two different frameworks measuring overlapping but not identical things.
For §409A’s stock-right exemption, the relevant comparison is the strike price and the underlying qualifying stock’s FMV at grant. An accounting valuation may instead measure the option award, with its own exercise and payment terms. Identify the object, date and purpose of each measurement before comparing numbers; do not describe common-stock FMV as a universal floor for an option’s accounting value.
Have the valuation specialist and accountant reconcile differences in the underlying common-stock assumptions. Do not automatically reprice existing options merely because two reports contain different numbers; determine what each report measures and whether the original grant was properly priced.
Common Mistakes Founders Make with 409A Valuations
The same mistakes show up repeatedly.
Mistake #1: Granting options without supportable grant-date FMV. A later, higher valuation does not by itself prove the earlier grant was discounted or trigger immediate grant-date income. Reconstruct the contemporaneous facts and analyze any coverage, pricing or operational failure.
Mistake #2: Substituting a financing headline for common-stock FMV. Consider the financing evidence, capitalization and rights of the actual shares. An independent valuation is a useful route, but not the only permissible method.
Mistake #3: Assuming a 409A valuation remains usable for new grants indefinitely. A valuation is a snapshot as of a specific date. If later information materially affects value—new funding, a major revenue change, market disruption, or other developments—continued reliance for new grants can be unreasonable. Existing properly priced grants are a separate question from whether an old calculation may still be used for the next grant.
Mistake #4: Judging validity by price or by whether the preparer is an insider. Test the method, qualifications and applicable safe harbor. A qualified insider can prepare an eligible illiquid-startup valuation; a costly outside report can still be deficient. Choose a provider or permitted internal approach that can explain and support the work. Review relevant experience, scope, independence where required, and the information considered.
Mistake #5: Ignoring material new information. Reassess after a material financing or other development before further grants. Common-stock FMV may properly differ from the preferred-stock price, but that difference needs support.
Mistake #6: Confusing a board-approved financing cap with option-pricing FMV. Board approval alone does not establish a reasonable valuation or a safe harbor. Identify the purpose, date, share class and per-share amount adopted.
The Consequences of Getting It Wrong: Section 409A Penalties
The tax consequences depend on the affected arrangement and the nature of the failure.
Under §409A(a)(1), a failure can require inclusion of affected deferred amounts that are no longer subject to a substantial risk of forfeiture and have not previously been included in income, with applicable plan aggregation. It does not automatically tax every unvested option or establish inclusion by comparing two headline company valuations.
Section 409A adds a 20% federal tax on the includible compensation, plus an interest-based additional tax calculated using the underpayment rate plus one percentage point and the statutory timing rule. The amount depends on the affected compensation and tax facts; headline company valuations alone cannot establish an employee’s tax bill.
Company reporting and withholding obligations require separate analysis. Additional penalties depend on the particular obligation and facts; an employee’s Section 409A inclusion does not automatically establish a corporate negligence or fraud penalty.
A failure can leave an employee owing tax before receiving cash. Determine the affected compensation, reporting obligations, and any available correction route before communicating the result.
Review tax compliance and corporate decision-making separately. A valuation problem alone does not establish a breach of fiduciary duty.
How Often Should Grant-Date FMV Support Be Refreshed (and How Long May a Value Be Used)?
For pricing new stock rights, Treas. Reg. §1.409A-1(b)(5)(iv)(B)(1) does impose a 12-month limit on using a previously calculated value. It also rejects a calculation that omits later information materially affecting value. Existing properly granted options do not need to be repriced simply because that valuation becomes old.
For a new grant, a previously calculated value more than 12 months old is not reasonable under the regulation. A younger value may also be unusable; the 12-month limit is not guaranteed validity.
Reflect intervening information materially affecting value before relying on the calculation for new grants. Do not assume that commissioning an update creates a grace period while the work remains unfinished.
A new grant does not necessarily require a brand-new report. Review the prior value’s age, intervening information, and continued satisfaction of any safe-harbor conditions. Use the underlying per-share value and actual grant terms—not a headline company valuation.
Practical Checklist: Getting or Updating a 409A Valuation
| 1. | Check timing before grants — Establish supportable FMV for the grants you plan to make. Do not rely on a value more than 12 months old, or on a calculation that omits intervening material information. A later report can analyze historical value but is not automatically retroactive safe-harbor protection or a cure; retain the valuation date and the actual preparation date. |
| 2. | Select the valuation route — Confirm the conditions for an independent appraisal, a qualifying illiquid-startup valuation, or a binding-formula safe harbor—or support the general reasonable-valuation standard. Compare provider scope, qualifications, independence where required, assumptions, report support, and current fees. |
| 3. | Organize the inputs — Assemble financial statements, the cap table, financing documents and term sheets, and other information the provider needs. Identify gaps and agree how they will be addressed. Agree on timing and required inputs before setting a grant date. |
| 4. | Review the analysis — Check methods, assumptions, capitalization, and share-class allocation. No particular named allocation method or report page count is universally mandated. A statement that a report is “409A compliant” is not conclusive. |
| 5. | Document authorization and retain records — Follow applicable board or delegated approval requirements. Retain the report, assumptions, supporting financial and capitalization records, valuation date, preparation date, and the date and terms of each grant authorization. Corporate authorization and the valuation safe harbor are separate questions; minutes alone do not prove compliance. |
| 6. | Check all award conditions—and communicate clearly — Price using supportable grant-date FMV and assess qualifying stock, deferral features, and other exemption requirements. Explain to employees what the option grants and what exercise costs; describe an appraisal as independent only when that is accurate. Valuation support does not guarantee liquidity or future option value. Budget for off-cycle updates around grant dates and material developments. |
The Strategic Importance of Getting This Right
Explain to employees what the option grants and what it costs to exercise. Valuation support helps establish pricing; it does not promise future value or liquidity.
A supportable valuation and a properly structured award reduce risk. An independent report supports the valuation analysis; it is not a shield from examination or from unrelated award defects.
Making new grants without supportable grant-date FMV creates pricing and documentation risk. Review material developments before subsequent grants. The passage of another quarter without a new valuation does not, by itself, create a defect in an existing properly priced grant.
If a defect is found, the remedy, cost, and timetable depend on the grant and the facts. Reissuing or repricing an award can have additional consequences and is not an automatic cure.
Frequently Asked Questions
What is a 409A valuation?
It is a determination of common-stock FMV used to support stock-right pricing—not a certificate that conclusively fixes value. See the opening and the safe-harbor section for the three presumption routes and what a valuation does and does not cover.
How much does a 409A valuation cost?
Fees depend on stage, capitalization, financing history, records, scope, and timing. Obtain current quotes that specify the report, update policy, and support.
How often should grant-date FMV support be refreshed?
For new grants, do not use a value more than 12 months old or one that omits intervening material information. Age alone does not reprice previously granted, properly priced options. See the refresh section above.
Who can perform a 409A valuation?
An independent-appraisal safe harbor requires an eligible independent appraisal. The illiquid-startup method can use a qualified insider if the company and valuation satisfy all its conditions. Qualifications depend on relevant knowledge, experience, education or training. A binding-formula safe harbor also exists under its specific conditions.
What happens if options were granted without an outside appraisal?
The absence of an outside appraisal alone does not establish discounted pricing or a §409A violation. Assess actual grant-date FMV, another possible valuation method, and all stock-right exemption conditions. A covered award that fails §409A can produce vested income inclusion, a 20% additional federal tax and an interest-based additional tax; employee and company reporting obligations need separate review.
Why can common-stock FMV differ from a financing valuation?
Preferred rights, capitalization, dates and valuation units can differ. Common stock may have a lower per-share value than preferred stock, but the regulation does not prescribe a 20–40% ratio or any other fixed discount. Do not compare a company-level valuation directly with a per-share option strike.
How long does a 409A valuation take?
Agree on the schedule and required inputs with the provider. Complexity, missing information, review and approval can affect delivery. Do not promise a universal rush window or set a grant date on the assumption that a report will arrive in time.
Do contractors and advisors need supportable FMV before receiving options?
Supportable grant-date FMV is important for compensatory options intended to fit the stock-right exemption, but that does not mean every contractor award requires a purchased third-party appraisal, and §409A does not apply categorically to every contractor arrangement. Reg. §1.409A-1(f)(2) excludes certain qualifying independent-contractor arrangements, subject to multiple-client and related-party conditions and limitations for board and management services. Separately, an option can qualify for the stock-right exemption. Contractor status alone neither establishes nor defeats an exemption.
Does Washington's new 9.9% income tax affect when employees should exercise options?
It can affect taxable NSO compensation recognized beginning in 2028, after applying Washington deductions, residency, sourcing and other rules. Spouses and registered domestic partners share one $1 million deduction in 2028. A qualifying ISO exercise-and-hold generally creates no ordinary income in federal AGI, although federal AMT can apply. A later sale requires its own analysis. There is no universal requirement to exercise all options before 2028.
Related Posts
If you found this helpful, you might also want to read:
- Section 83(b) Elections: What Startup Founders and Employees Need to Know
- Qualified Small Business Stock (QSBS): What Founders, Investors, Contractors and Employees Need to Know
- SAFE Agreements: What Every Startup Founder Needs to Know
- Stock Option Exercise Timing and Washington Income Tax
- Where Should I Incorporate My Business?
Questions About Option Pricing or Valuation Support?
If you need help reviewing option terms, grant approvals, or valuation support, reach out. The scope depends on the company’s records and proposed awards.
Related: 83(b) guide
Have questions about your specific situation?
Joe Wallin is a startup and tax attorney with 25+ years of experience advising founders and investors. Book a 20-minute call to discuss your situation.
Book a Free 20-Minute Call →This post is for educational purposes only and is not legal or tax advice. Consult a qualified attorney about your specific situation.